Status: current, Defined. Date: 31-Mar 2015. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1386901000168112 | Amoxycillin and Clavulanic Acid 125/31.25 (Apo) (amoxicillin 125 mg / 5 mL + clavulanic acid 31.25 mg / 5 mL) powder for oral liquid, 5 mL measure (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1386911000168110 | Amoxycillin and Clavulanic Acid 125/31.25 (Apo) powder for oral liquid, 5 mL | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2574671000168111 | Amoxycillin and Clavulanic Acid 125/31.25 (Apo) (amoxycillin 125 mg / 5 mL + clavulanic acid 31.25 mg / 5 mL) powder for oral liquid, 5 mL measure | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Amoxycillin and Clavulanic Acid 125/31.25 (Apo) powder for oral liquid, 5 mL | has Australian BoSS | clavulanic acid | true | Inferred relationship | Some | 1262431648 | |
| Amoxycillin and Clavulanic Acid 125/31.25 (Apo) powder for oral liquid, 5 mL | has unit of use | measure | true | Inferred relationship | Some | 1262431649 | |
| Amoxycillin and Clavulanic Acid 125/31.25 (Apo) powder for oral liquid, 5 mL | has Australian BoSS | amoxicillin | true | Inferred relationship | Some | 1121790016 | |
| Amoxycillin and Clavulanic Acid 125/31.25 (Apo) powder for oral liquid, 5 mL | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Amoxycillin and Clavulanic Acid 125/31.25 (Apo) powder for oral liquid, 5 mL | Is a | Amoxycillin and Clavulanic Acid 125/31.25 (Apo) | true | Inferred relationship | Some | ||
| Amoxycillin and Clavulanic Acid 125/31.25 (Apo) powder for oral liquid, 5 mL | Is a | amoxicillin 125 mg/5 mL + clavulanic acid 31.25 mg/5 mL powder for oral liquid | true | Inferred relationship | Some | ||
| Amoxycillin and Clavulanic Acid 125/31.25 (Apo) powder for oral liquid, 5 mL | has intended active ingredient | clavulanic acid | true | Inferred relationship | Some | 1262431648 | |
| Amoxycillin and Clavulanic Acid 125/31.25 (Apo) powder for oral liquid, 5 mL | has manufactured dose form | powder for oral liquid | true | Inferred relationship | Some | ||
| Amoxycillin and Clavulanic Acid 125/31.25 (Apo) powder for oral liquid, 5 mL | has intended active ingredient | amoxicillin | true | Inferred relationship | Some | 1121790016 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Amoxycillin and Clavulanic Acid 125/31.25 (Apo) powder for oral liquid, 75 mL | has TPUU | True | Amoxycillin and Clavulanic Acid 125/31.25 (Apo) powder for oral liquid, 5 mL | Inferred relationship | Some | 1 |
| Amoxycillin and Clavulanic Acid 125/31.25 (Apo) (amoxicillin 125 mg / 5 mL + clavulanic acid 31.25 mg / 5 mL) powder for oral liquid, 75 mL, bottle (containered trade product pack) | has TPUU | True | Amoxycillin and Clavulanic Acid 125/31.25 (Apo) powder for oral liquid, 5 mL | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR